Skip to main content
BMJ Open logoLink to BMJ Open
. 2021 Aug 2;11(8):e046749. doi: 10.1136/bmjopen-2020-046749

Complex multimorbidity and mortality in Japan: a prospective propensity-matched cohort study

Daisuke Kato 1,, Ichiro Kawachi 2, Junko Saito 3, Naoki Kondo 4
PMCID: PMC8330573  PMID: 34341044

Abstract

Objectives

There are limitations to defining multimorbidity (MM) based on a simple count of diseases. To address these limitations, the concept of complex MM (CMM) focuses on how many body systems are affected in a single patient, rather than counting comorbid conditions. This study compared the prediction of mortality among older Japanese adults between CMM and conventional MM.

Design

A population-based prospective cohort study.

Setting

The Japan Gerontological Evaluation Study, a nationwide longitudinal cohort study, which ran from 2010 to 2016.

Participants

Functionally independent individuals who were older than 65 and had complete illness data at the time of baseline survey were eligible.

Outcomes measure

CMM was defined as the coexistence of 3 or more body system disorders at baseline. We calculated the propensity for each individual to develop CMM based on a wide array of characteristics, including socioeconomic status and health behaviours. Individuals with and without CMM were then matched on their propensity scores before we estimated overall survival using a log-rank test.

Results

Our 6-year follow-up included 38 889 older adults: 20 233 (52.0%) and 7565 (19.5%) adults with MM and CMM, respectively. In the MM-matched cohort (n=15 666 pairs), the presence of MM was significantly associated with increased mortality (HR 1.07; 95% CI 1.01 to 1.14; p=0.02 by the log-rank test). A similar mortality association was found in the CMM-matched cohort (n=7524 pairs, HR, 1.07; 95% CI 0.99 to 1.16; p=0.08 by the log-rank test).

Conclusion

This is the first study to report the association between CMM and mortality among older adults in Japan. MM and CMM predict mortality in older adults to a similar degree. This finding needs to be replicated with more precision in larger samples.

Keywords: social medicine, epidemiology, geriatric medicine, multimorbidity


Strengths and limitations of this study.

  • This is the first study to directly compare the associations between two alternative formulations of multimorbidity—conventional multimorbidity and complex multimorbidity—and survival in a nationwide cohort of older Japanese adults.

  • We used propensity score matching to minimise confounding bias when comparing the survival of individuals with and without multimorbidity.

  • One limitation is that we did not take into account the severity of disease at baseline, which may have underestimated the impact of comorbid conditions.

Introduction

There are limitations in defining multimorbidity (MM; the co-occurrence of diseases in the same person) based on a simple count of diseases,1 and a new concept of ‘complex MM’ (CMM) has thus been proposed.2 CMM focuses on the impact across the different body systems rather than counting comorbid conditions.

In CMM, diseases are categorised by the body system they affect. Because impairments of the same body system often have similar interventions, their impacts on patient prognosis are expected to be similar. Therefore, it makes biological sense to combine closely related diseases (eg, osteoporosis and fractures) as affecting a single body system (ie, musculoskeletal and connective disorders) rather than counting them as two separate diseases when evaluating the impact of multiple comorbid conditions. In turn, disorders of different body systems should be counted separately because they need more complex and extensive treatment, and the treatment of one disease may adversely affect another. Furthermore, from a methodological perspective, focusing on body system disorders may be more reliable method for collecting patient self-report data as patients are apt to misclassify individual conditions (eg, osteoarthritis vs rheumatoid arthritis or asthma vs COPD (chronic obstructive pulmonary disease)) but they are unlikely to mistake the affected body system. CMM is also likely to be a more reliable method as it may avoid issues of whether a clinician sees two very similar diseases as distinct and thereby avoids the issue of some clinicians recording a single condition while others record two.

A growing number of studies have demonstrated the negative impact of MM on patient outcomes, showing that MM is associated with mortality, reduced quality of life, lower physical functioning and so on.1 3–6 In many reports claiming these associations, researchers have attempted to weight diseases according to severity. Although the MM approach is better than conventional medical care that tends to focus on a single disease at a time, the new concept of CMM that focuses on multiple body system disorders is expected to result in stronger predictions of patient outcomes.

There is little evidence on the impact of CMM on mortality.7 Although functional disability is associated with mortality, no previous studies have evaluated the impact of CMM by considering baseline activities of daily living status. Furthermore, previous reports that include both MM and CMM mainly performed descriptive statistics, not inferential statistics.8–11 Against this background, we used CMM and conventional MM to compare the predictions of mortality among older Japanese adults.

Methods

Data sources

We conducted this study using the longitudinal nationwide cohort data from the Japan Gerontological Evaluation Study (JAGES),12 which was established in 2010. This study focuses on adults in Japan over 65 years of age and aims to establish a society of healthy longevity.

Study population

Self-administered questionnaires for the baseline survey were mailed to 95 827 older adults in Japan between August 2010 and January 2012. Adults were sampled from 13 municipalities in 7 of the 47 prefectures in Japan. All adults were functionally independent, which was defined as not receiving public long-term care (LTC) insurance. The municipalities were from three of the four major islands of Japan (Hokkaido, Honshu, Kyushu).

Among the target population, 62 426 individuals responded to the survey (response rate, 65.1%). We included individuals who were functionally independent and not receiving any nursing care or home care assistance to avoid reverse causality between MM and functional disability, which is a key factor in mortality. We included individuals who had valid ID, sex, and age information, and who were linked to LTC insurance certification registers. We excluded individuals whose functional disability status at baseline was unknown, or who were already receiving nursing care or home care assistance, or whose data on the history of present illness was missing. Finally, we identified a cohort of 38 889 individuals. Further details of the cohort flow diagram are shown in figure 1.

Figure 1.

Figure 1

Flow diagram of the sample group. ADL, activities of daily living.

MM and CMM

At baseline, 19 diseases were surveyed in the JAGES. Among them, as noted in table 1, we analysed the following 17 diseases to calculate MM and CMM: heart disease (including arrhythmia), stroke, high blood pressure, diabetes (including mild type), obesity, dyslipidaemia, impaired vision, gastrointestinal disease, liver disease, impaired hearing, mental disease, sleep problems, osteoporosis, joint disease/neuralgia, injury/fracture, cancer and respiratory disease. The remaining two symptoms, difficulty swallowing and difficulty with bowel movements, were excluded from the disease list in this study because they have aspects of dysfunction not disease. The JAGES did not survey diseases of the nervous system.

Table 1.

Definition of body system categories in CMM and diseases surveyed in JAGES

Category Disease
Circulation disorder
  • Heart disease (including arrhythmia)

  • Stroke

  • High blood pressure

Endocrine-metabolic disorder (general system)
  • Diabetes (including mild type)

  • Obesity

  • Dyslipidaemia

Eye disorder
  • Impaired vision

Gastrointestinal disorder
  • Gastrointestinal disease

  • Liver disease

Hearing disorder
  • Impaired hearing

Mental and behavioural disorder
  • Mental disease

  • Sleep problem

Musculoskeletal and connective disorder
  • Osteoporosis

  • Joint disease/neuralgia

  • Injury/fracture

Neoplasm
  • Cancer

Respiratory disorder
  • Respiratory disease

CMM, complex multimorbidity; JAGES, the Japan Gerontological Evaluation Study

MM was defined as having two or more of the aforementioned diseases concurrently. For CMM, the diseases surveyed were categorised according to the body system they affected.2 13 For example, heart disease and diabetes were individually categorised into disorders of the circulatory system and endocrine system. Next, CMM was defined as the coexistence of 3+ body system disorders at baseline (see table 1).

Outcome

The outcome of this study was the 6-year incidence of mortality. We ascertained vital status from 2010 to 2016 by linking the cohort participants to the mortality records of the national LTC insurance database (follow-up rate=96.2%). The mean follow-up period was 5.6 years, and we observed 5183 (13.3%) deaths during the period.

Statistical analysis

Estimation of missing data

Given that the missing data was missing at random, we conducted multiple imputations using a bootstrapping Expectation-Maximisation algorithm.14 We analysed 20 multiply imputed datasets, taking the low missing rate of the cohort (approximately 5%) into consideration.15 Lastly, we combined all estimators by Rubin’s rule.16

Propensity score matching

We used propensity score matching to compare overall survival among individuals with and without MM/CMM. To address potential confounding bias, we conducted propensity score matching within a logistic regression framework. The participant information included in estimating the propensity score consisted of 44 variables: age, sex, smoking status, alcohol consumption, marital status, pension, dental health, employment status, consumption of meat of fish/fruits or vegetable, education, city code and so on (see online supplemental table S1).

Supplementary data

bmjopen-2020-046749supp001.pdf (254.1KB, pdf)

We performed a 1:1 matching between individuals with and without MM/CMM using the nearest-neighbour method within a calliper (0.2 of the SD of the logit of the propensity score).17 18 We evaluated the covariate balance after matching using standardised differences. An absolute standardised difference of less than 0.1 was considered negligible in the groups (see tables 2 and 3).

Table 2.

Demographic characteristics of the cohort study

Characteristic With MM Without MM With CMM Without CMM
Sample size 20 233 18 656 7565 31 324
Age
 65–69 4087 43.4 5328 56.6 1205 12.8 8210 87.2
 70–74 5673 49.7 5745 50.3 1955 17.1 9463 82.9
 75–79 5413 56.7 4134 43.3 2162 22.6 7385 77.4
 80–84 3418 59.2 2352 40.8 1485 25.7 4285 74.3
 85–89 1322 60.3 870 39.7 605 27.6 1587 72.4
 90+ 320 58.5 227 41.5 153 28.0 394 72.0
 Missing 0 0 0 0
Sex
 Male 8803 49.3 9038 50.7 3051 17.1 14 790 82.9
 Female 11 430 54.3 9618 45.7 4514 21.4 16 534 78.6
 Missing 0 0 0 0
No of natural teeth
 20 or more 5979 48.6 6313 51.4 2020 16.4 10 272 83.6
 10–19 4946 51.3 4686 48.7 1807 18.8 7825 81.2
 1–9 5478 54.5 4582 45.5 2170 21.6 7890 78.4
 No natural teeth 3174 56.1 2484 43.9 1311 23.2 4347 76.8
 Missing 656 52.6 591 47.4 257 20.6 990 79.4
Formal education years
 Less than 6 years 582 58.6 412 41.4 296 29.8 698 70.2
 6–9 years 9812 54.2 8297 45.8 3818 21.1 14 291 78.9
 10–12 years 6234 49.9 6250 50.1 2247 18.0 10 237 82.0
 13 years or more 3091 49.1 3208 50.9 997 15.8 5302 84.2
 Other 125 50.6 122 49.4 52 21.1 195 78.9
 Missing 389 51.5 367 48.5 155 20.5 601 79.5
Marital status
 Married 13 555 50.4 13 328 49.6 4772 17.8 22 111 82.2
 Widowed 5124 56.5 3944 43.5 2171 23.9 6897 76.1
 Divorced 652 52.3 594 47.7 255 20.5 991 79.5
 Never married 413 55.5 331 44.5 157 21.1 587 78.9
 Other 108 50.2 107 49.8 48 22.3 167 77.7
 Missing 381 52.0 352 48.0 162 22.1 571 77.9
Living arrangement
 Live alone 17 195 51.5 16 169 48.5 6300 18.9 27 064 81.1
 Not alone 2730 56.1 2138 43.9 1159 23.8 3709 76.2
 Missing 308 46.9 349 53.1 106 16.1 551 83.9
Financial insecurity (worries about unexpected expenses)
 None at all 1858 47.9 2018 52.1 608 15.7 3268 84.3
 Slight 8218 49.6 8357 50.4 2817 17.0 13 758 83.0
 Moderate 5556 54.2 4701 45.8 2144 20.9 8113 79.1
 Severe 3431 57.9 2494 42.1 1554 26.2 4371 73.8
 Missing 1170 51.9 1086 48.1 442 19.6 1814 80.4
Receiving pension
 No 19 191 51.9 17 779 48.1 7162 19.4 29 808 80.6
 Yes 277 57.0 209 43.0 109 22.4 377 77.6
 Missing 765 53.4 668 46.6 294 20.5 1139 79.5
Current employment status
 Has a paid job 3259 44.6 4055 55.4 952 13.0 6362 87.0
 Retired 11 344 53.0 10 040 47.0 4315 20.2 17 069 79.8
 Never had a job 2623 56.2 2043 43.8 1125 24.1 3541 75.9
 Missing 3007 54.4 2518 45.6 1173 21.2 4352 78.8
Alcohol consumption
 Yes 5640 47.8 6164 52.2 1868 15.8 9936 84.2
 Used to drink 840 57.2 628 42.8 354 24.1 1114 75.9
 No 12 498 53.8 10 733 46.2 4844 20.9 18 387 79.1
 Missing 1255 52.6 1131 47.4 499 20.9 1887 79.1
Smoking status
 Never smoked 10 990 52.8 9842 47.2 4195 20.1 16 637 79.9
 Stopped smoking 5 or more years ago 4499 52.4 4086 47.6 1609 18.7 6976 81.3
 Stopped smoking within the past 4 years 913 50.4 899 49.6 334 18.4) 1478 81.6
 Current smoker 1632 46 1918 54 546 15.4 3004 84.6
 Missing 2199 53.5 1911 46.5 881 21.4 3229 78.6

CMM, complex multimorbidity; MM, multimorbidity

Table 3.

Standardised mean differences with or without MM/CMM, before and after propensity score matching

MM CMM
SMD in multiply imputed data SMD in matching data SMD in multiply imputed data SMD in matching data
Characteristic
 Age  0.24  0.002  0.327  0.025
 Sex  0.099  0.001  0.139  0.004
 Previous health check-up  0.01  0.015  0.02  0.005
 No of natural teeth  0.11  0.019  0.16  0.005
 Consumption of meat and fish  0.009  0.017  0.017  0.016
 Consumption of fruits and vegetables  0.003  0.006  0.035  0.012
 Formal educational years  0.093  0.045  0.151  0.004
 Marital status  0.072  0.015  0.118  0.002
 Living arrangement  0.06  0.033  0.1  0.011
 Residence type  0.025  0.055  0.058  0.008
 Architectural type of home  0.005  0.086  0.02  0.006
 Financial insecurity  0.123  0.004  0.21  0.012
 Receiving pension  0.023  0.022  0.022  0.006
 Current working status  0.147  0.002  0.225  0.004
 Eats meals alone  0.089  0.02  0.17  0.014
 Alcohol consumption  0.107  0.015  0.145  0.013
 Smoking status  0.079  0.014  0.098  0.016
 Falls  0.223  0.004  0.307  0.013
 Worries about falls  0.266  0.001  0.396  0.005
 Goes upstairs without support  0.265  0.009  0.348  0.005
 Gets up out of a chair without support  0.251  0.02  0.343  0.01
 Average time to walk  0.16  <0.001  0.203  0.001
 Frequency of going out  0.151  0.015  0.207  0.003
 Decrease in the frequency of going out  0.243  0.001  0.352  0.006
 Engagement in leisure activities  0.105  0.016  0.145  0.008
 Trust in neighbours  0.079  0.027  0.135  0.009
 Support from neighbours  0.074  0.015  0.109  0.002
 Attachment to residence  0.053  0.036  0.086  0.002
 Contribution to residence  0.095  0.009  0.129  0.007
 Uneasiness about safety in residence  0.073  0.011  0.105  0.01
 Participation in local events  0.085  0.009  0.114  0.008
 Interactions with neighbourhood  0.02  0.031  0.049  0.007
Residential environment:
 Presence of graffiti or garbage  0.009  0.02  0.019  0.014
 Parks or footpaths  0.059  0.045  0.097  <0.001
 Locations difficult for walking  0.076  0.012  0.132  0.007
 Risky roads or crossroads for traffic accidents  0.044  0.005  0.061  0.002
 Aesthetic views or buildings  0.04  <0.001  0.074  0.004
 Shops selling fresh fruits and vegetables  0.074  0.023  0.091  0.001
 Dangerous place to walk alone at night  0.013  0.019  0.016  <0.001
 Comfortable house or facilities  0.066  0.024  0.107  0.011
 Someone who listens to your concerns  0.019  0.01  0.075  0.007
 Someone to provide care in case of illness  0.049  0.023  0.094  0.026
Attendance
 Sports group or club  0.063  0.008  0.117  0.031
 Leisure activity group  0.06  0.006  0.088  0.007

CMM, complex multimorbidity; MM, multimorbidity; SMD, standardised mean difference

Survival data analysis

We estimated the overall survival using Kaplan-Meier curves.18 We also compared overall survival between matched with and without MM/CMM groups using a log-rank test.

Sensitivity analysis

While the definition of MM we adopted in this study is one of the most commonly used definitions in previous studies,2 we analysed this cohort data with a more sensitive approach. Specifically, we analysed the association between the number of diseases or body system disorders and the mortality by multivariate analysis with the covariates used in the propensity score calculation. The results of this analysis did not change the direction or significance of the MM/CMM effect (data not shown).

We used R software packages (V.4.0.1) for all statistical analyses, and the statistical significance level was 0.05 for all analyses.

Patient and public involvement

This was a nationwide cohort study focusing on community-dwelling individuals. No patients and the public were involved in this research.

Results

Baseline population characteristics

Among the current cohort study, 20 233 (52.0%) participants out of 38 889 had MM and 7565 (19.5%) had CMM. Table 2 presents the demographic characteristics of the cohort study. Table 3 summarises the background characteristics of the participants between the two groups before and after matching. Populations with MM/CMM were more likely to be older, were more likely to have fewer teeth, and were more vulnerable to financial insecurity (worries about unexpected expenses) compared with those without MM/CMM. Furthermore, compared with populations with MM, populations with CMM were more likely to be female, to have lower education, to eat meals alone and to be unmarried.

MM outcome

After the 1:1 propensity score matching, 31 332 patients were recruited and evenly classified into propensity-matched MM and propensity-matched non-MM groups. The C-statistics before matching for evaluation of the discriminatory ability of the propensity score model was 0.64 (95% CI 0.63 to 0.64).19 The two matched cohorts were well balanced (see table 3). The populations with MM had a 7% higher mortality than those without MM as shown in figure 2 (HR 1.07; 95% CI 1.01 to 1.14; p=0.02 by the log-rank test).

Figure 2.

Figure 2

Kaplan-Meier curve for overall survival comparing patients with and without MM. MM, multimorbidity.

CMM outcome

After the 1:1 propensity score matching, 15 048 patients were recruited and evenly classified into propensity-matched CMM and propensity-matched non-CMM groups. The C-statistics before matching for evaluation of the discriminatory ability of the propensity score model was 0.69 (95% CI 0.68 to 0.69).19 The two matched cohorts were well balanced (see table 3). The populations with CMM had slightly higher mortality than those without CMM as shown in figure 3 (HR, 1.07; 95% CI 0.99 to 1.16; p=0.08 by the log-rank test).

Figure 3.

Figure 3

Kaplan-Meier curve for overall survival comparing patients with and without CMM. CMM, complex multimorbidity.

Discussion

To the best of our knowledge, this is the first study to report the association between CMM and mortality among older adults in Japan. MM and CMM predict mortality in older adults to a similar degree.

MM is both an individual and a social issue. Low socioeconomic status (SES) individuals develop MM roughly 10–15 years earlier compared with high SES individuals.20 Therefore, to evaluate whether the presence of MM/CMM is causally related to mortality, SES should be considered as a confounding factor. There were larger intergroup differences in baseline variables for the CMM-matched cohort compared with the MM-matched cohort. Although CMM was already known to be associated with lower SES,21 the current findings indicate that CMM may be more closely related to social factors than MM.

We found that the impact of MM and CMM on mortality was similar. Furthermore, CMM was marginally statistically significantly associated with mortality. This may be partly because the current study did not consider disease severity or disease status except in the baseline survey. That is, it may not sufficiently represent body system disorders in terms of the number of disease groups affected. This finding needs to be replicated with more precision in larger samples.

There are several limitations to this study. First, the self-administered questionnaire was the basis for disease information, which may have led to recall bias. This reporting error may lead to bias in either direction because its extent depends on the type of disease and age.22 Second, although the results are based on a nationwide cohort study, the participants were not nationally representative, and hence external generalisability is not assured. The response rate (around 65%) was comparable to that of other cohort studies for community-dwelling individuals. Third, because this study was observational, our findings cannot be interpreted as indicating causality. Nonetheless, we attempted to minimise confounding bias through the use of propensity score matching.18

Conclusion

Both MM and CMM predicted future mortality among older adults in Japan. These findings indicate the importance of the interactive effects of multiple diseases.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

The authors are grateful to all of the staff who conducted the baseline and follow-up surveys, all survey participants, and JAGES group members.

Footnotes

Contributors: All authors (DK, IK, JS and NK) made contributions to the conception and design of this study. DK analysed the data and authored the paper. IK checked the results and advised edits. All authors agreed on the final version of this manuscript.

Funding: This study used data from JAGES (the Japan Gerontological Evaluation Study). This study was supported by the Japan Society for the Promotion of Science, KAKENHI Grant (JP15H01972), Health Labour Sciences Research Grant (H28-Choju-Ippan002), Japan Agency for Medical Research and Development (JP17dk0110017, JP18dk0110027, JP18ls0110002, JP18le0110009, JP20dk0110034, JP20dk0110037), Open Innovation Platform with Enterprises, Research Institute and Academia (OPERA, JPMJOP1831) from the Japan Science and Technology (JST), a grant from Innovative Research Program on Suicide Countermeasures(1-4), a grant from Sasakawa Sports Foundation, a grant from Japan Health Promotion & Fitness Foundation, a grant from Chiba Foundation for Health Promotion & Disease Prevention, the 8020 Research Grant for fiscal 2019 from the 8020 Promotion Foundation (adopted number: 19-2-06), a grant from Niimi Universit (1915010), grants from Meiji Yasuda Life Foundation of Health and Welfare and the Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (29-42, 30-22).

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Data availability statement

Data are available on reasonable request. Data are from the JAGES study. All inquiries are to be addressed to the data management committee via email: dataadmin.ml@jages.net. All JAGES datasets have ethical and legal restrictions for public deposition due to the inclusion of sensitive information from human participants.

Ethics statements

Patient consent for publication

Not required.

Ethics approval

JAGES participants were informed that participation was voluntary and that their consent to participate in the study was shown by returning the questionnaire via mail. The Nihon Fukushi University Ethics Committee (no. 10-5), National Center for Geriatrics and Gerontology (no. 992-2), and Chiba University Ethics Committee (no. 2493) approved the parent JAGES protocol.

References

  • 1.Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 2014;9:e102149. 10.1371/journal.pone.0102149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Johnston MC, Crilly M, Black C, et al. Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health 2019;29:182–9. 10.1093/eurpub/cky098 [DOI] [PubMed] [Google Scholar]
  • 3.Wei MY, Mukamal KJ. Multimorbidity, mortality, and long-term physical functioning in 3 prospective cohorts of community-dwelling adults. Am J Epidemiol 2018;187:103–12. 10.1093/aje/kwx198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.John PDS, Tyas SL, Menec V. Multimorbidity, disability, and mortality in community-dwelling older adults. Can Fam Physician 2014;60:272–80. [PMC free article] [PubMed] [Google Scholar]
  • 5.Tooth L, Hockey R, Byles J, et al. Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women. J Clin Epidemiol 2008;61:151–9. 10.1016/j.jclinepi.2007.05.015 [DOI] [PubMed] [Google Scholar]
  • 6.Nunes BP, Flores TR, Mielke GI, et al. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr 2016;67:130–8. 10.1016/j.archger.2016.07.008 [DOI] [PubMed] [Google Scholar]
  • 7.Storeng SH, Vinjerui KH, Sund ER, et al. Associations between complex multimorbidity, activities of daily living and mortality among older Norwegians. A prospective cohort study: the HUNT study, Norway. BMC Geriatr 2020;20:1–8. 10.1186/s12877-020-1425-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Harrison C, Henderson J, Miller G, et al. The prevalence of diagnosed chronic conditions and multimorbidity in Australia: a method for estimating population prevalence from general practice patient encounter data. PLoS One 2017;12:e0172935. 10.1371/journal.pone.0172935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Singer L, Green M, Rowe F, et al. Social determinants of multimorbidity and multiple functional limitations among the ageing population of England, 2002–2015. SSM - Popul Heal 2019;8:1–9. 10.1016/j.ssmph.2019.100413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Harrison C, Henderson J, Miller G, et al. The prevalence of complex multimorbidity in Australia. Aust N Z J Public Health 2016;40:239–44. 10.1111/1753-6405.12509 [DOI] [PubMed] [Google Scholar]
  • 11.Lujic S, Simpson JM, Zwar N, et al. Multimorbidity in Australia: comparing estimates derived using administrative data sources and survey data. PLoS One 2017;12:e0183817. 10.1371/journal.pone.0183817 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kondo K. Progress in aging epidemiology in Japan: the JAGES project. J Epidemiol 2016;26:331–6. 10.2188/jea.JE20160093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622–6. 10.1111/j.1532-5415.1968.tb02103.x [DOI] [PubMed] [Google Scholar]
  • 14.Honaker J, King G, Blackwell M. A program for missing data. J Stat Softw 2011;45:1–47. 10.18637/jss.v045.i07 [DOI] [Google Scholar]
  • 15.Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? some practical clarifications of multiple imputation theory. Prev Sci 2007;8:206–13. 10.1007/s11121-007-0070-9 [DOI] [PubMed] [Google Scholar]
  • 16.Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473–89. 10.1080/01621459.1996.10476908 [DOI] [Google Scholar]
  • 17.Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55. 10.1093/biomet/70.1.41 [DOI] [Google Scholar]
  • 18.Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 2014;33:1242–58. 10.1002/sim.5984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Westreich D, Cole SR, Funk MJ, et al. The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf 2011;20:317–20. 10.1002/pds.2074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37–43. 10.1016/S0140-6736(12)60240-2 [DOI] [PubMed] [Google Scholar]
  • 21.Vinjerui KH, Bjerkeset O, Bjorngaard JH, et al. Socioeconomic inequalities in the prevalence of complex multimorbidity in a Norwegian population: findings from the cross-sectional HUNT study. BMJ Open 2020;10:e036851. 10.1136/bmjopen-2020-036851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fortin M, Haggerty J, Sanche S, et al. Self-Reported versus health administrative data: implications for assessing chronic illness burden in populations. A cross-sectional study. CMAJ Open 2017;5:E729–33. 10.9778/cmajo.20170029 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2020-046749supp001.pdf (254.1KB, pdf)

Reviewer comments
Author's manuscript

Data Availability Statement

Data are available on reasonable request. Data are from the JAGES study. All inquiries are to be addressed to the data management committee via email: dataadmin.ml@jages.net. All JAGES datasets have ethical and legal restrictions for public deposition due to the inclusion of sensitive information from human participants.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES